Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa.

Pakhchanian, Haig; Raiker, Rahul; DeYoung, Charles; Yang, Sherry

Pakhchanian, Haig; Raiker, Rahul; DeYoung, Charles; Yang, Sherry.

Affiliation

Pakhchanian H; School of Medicine and Health Science, George Washington University, Washington, DC, USA.
Raiker R; School of Medicine, West Virginia University, Morgantown, WV, USA.
DeYoung C; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Yang S; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University Hospital, Philadelphia, PA, USA.

Clin Exp Dermatol ; 47(6): 1186-1188, 2022 06.

Article in En | MEDLINE | ID: mdl-35179254

Subject(s)

COVID-19; Hidradenitis Suppurativa; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Hidradenitis Suppurativa/complications; Humans; Severity of Illness Index; Vaccination/adverse effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hidradenitis Suppurativa / COVID-19 Limits: Humans Language: En Journal: Clin Exp Dermatol Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google